Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder: 3- and 12-month follow-up of a randomized controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder : 3- and 12-month follow-up of a randomized controlled trial. / Jørgensen, Mie Sedoc; Storebø, Ole Jakob; Bo, Sune; Poulsen, Stig; Gondan, Matthias; Beck, Emma; Chanen, Andrew M; Bateman, Anthony; Pedersen, Jesper; Simonsen, Erik.

In: European Child & Adolescent Psychiatry, 09.05.2020.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jørgensen, MS, Storebø, OJ, Bo, S, Poulsen, S, Gondan, M, Beck, E, Chanen, AM, Bateman, A, Pedersen, J & Simonsen, E 2020, 'Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder: 3- and 12-month follow-up of a randomized controlled trial', European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-020-01551-2

APA

Jørgensen, M. S., Storebø, O. J., Bo, S., Poulsen, S., Gondan, M., Beck, E., ... Simonsen, E. (2020). Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder: 3- and 12-month follow-up of a randomized controlled trial. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-020-01551-2

Vancouver

Jørgensen MS, Storebø OJ, Bo S, Poulsen S, Gondan M, Beck E et al. Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder: 3- and 12-month follow-up of a randomized controlled trial. European Child & Adolescent Psychiatry. 2020 May 9. https://doi.org/10.1007/s00787-020-01551-2

Author

Jørgensen, Mie Sedoc ; Storebø, Ole Jakob ; Bo, Sune ; Poulsen, Stig ; Gondan, Matthias ; Beck, Emma ; Chanen, Andrew M ; Bateman, Anthony ; Pedersen, Jesper ; Simonsen, Erik. / Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder : 3- and 12-month follow-up of a randomized controlled trial. In: European Child & Adolescent Psychiatry. 2020.

Bibtex

@article{5f0ba3381991425a9071f12ec4f8f5de,
title = "Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder: 3- and 12-month follow-up of a randomized controlled trial",
abstract = "Mentalization-based treatment in groups (MBT-G) has never been tested in adolescents with Borderline Personality Disorder (BPD) in a randomized controlled trial. The current study aimed to test the long-term effectiveness of MBT-G in an adolescent sample with BPD or BPD features (≥ 4 DSM-5 BPD criteria). Hundred and eleven patients with BPD (n = 106) or BPD features (n = 5) were randomized to either (1) a 1-year modified MBT-G program comprising three MBT introductory sessions, five individual case formulation sessions, 37 weekly MBT group sessions, and six MBT-Parent sessions, or (2) treatment as usual (TAU), defined as at least 12 individual monthly treatment sessions with follow-up assessments at 3 and 12 months post treatment. The primary outcome was the score on the Borderline Personality Features Scale for Children (BPFS-C), and secondary outcomes included clinician-rated BPD symptoms and global level of functioning as well as self-reported self-harm, depression, externalizing and internalizing symptoms, and caregiver reports. There were no statistically significant differences between MBT-G and TAU on the primary outcome measure or any of the secondary outcomes. Both groups showed improvement on the majority of clinical and social outcomes at both follow-up points, although remission rates were modest with just 35{\%} in MBT-G and 39{\%} in TAU 2 years after inclusion into the study. MBT-G was not superior to TAU in improving borderline features in adolescents. Although improvement was observed equally in both interventions over time, the patients continued to exhibit prominent BPD features, general psychopathology and decreased functioning in the follow-up period, which points to a need for more research and better understanding of effective components in early intervention programs. The ClinicalTrials.gov identifier is NCT02068326.",
keywords = "Faculty of Social Sciences, Mentalization-based treatment, Mentalizing, Adolescence, Borderline Personality Disorder, Group psychotherapy, Follow-up",
author = "J{\o}rgensen, {Mie Sedoc} and Storeb{\o}, {Ole Jakob} and Sune Bo and Stig Poulsen and Matthias Gondan and Emma Beck and Chanen, {Andrew M} and Anthony Bateman and Jesper Pedersen and Erik Simonsen",
year = "2020",
month = "5",
day = "9",
doi = "10.1007/s00787-020-01551-2",
language = "English",
journal = "European Child & Adolescent Psychiatry",
issn = "1018-8827",
publisher = "Springer Medizin",

}

RIS

TY - JOUR

T1 - Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder

T2 - 3- and 12-month follow-up of a randomized controlled trial

AU - Jørgensen, Mie Sedoc

AU - Storebø, Ole Jakob

AU - Bo, Sune

AU - Poulsen, Stig

AU - Gondan, Matthias

AU - Beck, Emma

AU - Chanen, Andrew M

AU - Bateman, Anthony

AU - Pedersen, Jesper

AU - Simonsen, Erik

PY - 2020/5/9

Y1 - 2020/5/9

N2 - Mentalization-based treatment in groups (MBT-G) has never been tested in adolescents with Borderline Personality Disorder (BPD) in a randomized controlled trial. The current study aimed to test the long-term effectiveness of MBT-G in an adolescent sample with BPD or BPD features (≥ 4 DSM-5 BPD criteria). Hundred and eleven patients with BPD (n = 106) or BPD features (n = 5) were randomized to either (1) a 1-year modified MBT-G program comprising three MBT introductory sessions, five individual case formulation sessions, 37 weekly MBT group sessions, and six MBT-Parent sessions, or (2) treatment as usual (TAU), defined as at least 12 individual monthly treatment sessions with follow-up assessments at 3 and 12 months post treatment. The primary outcome was the score on the Borderline Personality Features Scale for Children (BPFS-C), and secondary outcomes included clinician-rated BPD symptoms and global level of functioning as well as self-reported self-harm, depression, externalizing and internalizing symptoms, and caregiver reports. There were no statistically significant differences between MBT-G and TAU on the primary outcome measure or any of the secondary outcomes. Both groups showed improvement on the majority of clinical and social outcomes at both follow-up points, although remission rates were modest with just 35% in MBT-G and 39% in TAU 2 years after inclusion into the study. MBT-G was not superior to TAU in improving borderline features in adolescents. Although improvement was observed equally in both interventions over time, the patients continued to exhibit prominent BPD features, general psychopathology and decreased functioning in the follow-up period, which points to a need for more research and better understanding of effective components in early intervention programs. The ClinicalTrials.gov identifier is NCT02068326.

AB - Mentalization-based treatment in groups (MBT-G) has never been tested in adolescents with Borderline Personality Disorder (BPD) in a randomized controlled trial. The current study aimed to test the long-term effectiveness of MBT-G in an adolescent sample with BPD or BPD features (≥ 4 DSM-5 BPD criteria). Hundred and eleven patients with BPD (n = 106) or BPD features (n = 5) were randomized to either (1) a 1-year modified MBT-G program comprising three MBT introductory sessions, five individual case formulation sessions, 37 weekly MBT group sessions, and six MBT-Parent sessions, or (2) treatment as usual (TAU), defined as at least 12 individual monthly treatment sessions with follow-up assessments at 3 and 12 months post treatment. The primary outcome was the score on the Borderline Personality Features Scale for Children (BPFS-C), and secondary outcomes included clinician-rated BPD symptoms and global level of functioning as well as self-reported self-harm, depression, externalizing and internalizing symptoms, and caregiver reports. There were no statistically significant differences between MBT-G and TAU on the primary outcome measure or any of the secondary outcomes. Both groups showed improvement on the majority of clinical and social outcomes at both follow-up points, although remission rates were modest with just 35% in MBT-G and 39% in TAU 2 years after inclusion into the study. MBT-G was not superior to TAU in improving borderline features in adolescents. Although improvement was observed equally in both interventions over time, the patients continued to exhibit prominent BPD features, general psychopathology and decreased functioning in the follow-up period, which points to a need for more research and better understanding of effective components in early intervention programs. The ClinicalTrials.gov identifier is NCT02068326.

KW - Faculty of Social Sciences

KW - Mentalization-based treatment

KW - Mentalizing

KW - Adolescence

KW - Borderline Personality Disorder

KW - Group psychotherapy

KW - Follow-up

U2 - 10.1007/s00787-020-01551-2

DO - 10.1007/s00787-020-01551-2

M3 - Journal article

C2 - 32388627

JO - European Child & Adolescent Psychiatry

JF - European Child & Adolescent Psychiatry

SN - 1018-8827

ER -

ID: 241089799